Back

The use of wearable cardioverter defibrillator in France

1 September 2019 (16:48 - 16:57)
Organised by:
Congress Presentation Part of: Optimizing device therapy for arrhythmia Device Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Eloi Marijon

European Hospital Georges Pompidou, Paris (France)

7 More presentations in this session

Presentation thumbnail
Experience with the wearable cardioverter-defibrillator by disease etiology: results from the wearit-II registry
Associate Professor V. Kutyifa (Rochester, US)
Abstract Slides Video
Presentation thumbnail
When do cardiac rhythm management device complications occur?
Doctor C. Brough (Cheshire, GB)
Abstract Slides Video
Presentation thumbnail
Role of implantation access on complication rates in pacemaker implantation
Doctor K. Bestehorn (Dresden, DE)
Abstract Slides Video
Presentation thumbnail
Influence of transvenous lead extraction procedure on function of tricuspid apparatus
Professor A. Polewczyk (Kielce, PL)
Abstract Slides Video
Presentation thumbnail
How can we improve the success of cardiac resynchronization therapy implantation?
Doctor A. Nunes Ferreira (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Optimizing device therapy for arrhythmia

The Event

Event poster

ESC Congress 2019

1 September 2019 16:48 CET
You may be interested in
thumbnail
Congress Presentation
The use of wearable cardioverter defibrillator among patients suffering from myocarditis: data from a multicenter registry
thumbnail
Congress Presentation
Wearable cardioverter defibrillator after ICD-system explantation: data from a multicenter registry
thumbnail
Congress Presentation
Implantable Cardioverter-Defibrillator - do we have alternative predictors to administered shocks?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources